| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/01/1996 | WO1996002567A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | WO1996002560A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002556A2 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002546A1 Water-soluble esters of camptothecin compounds |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002247A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 02/01/1996 | WO1996002243A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 02/01/1996 | WO1996002242A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 02/01/1996 | WO1996002143A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 02/01/1996 | WO1995013385A3 Thrombin mutants |
| 02/01/1996 | DE4426601A1 Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri Use of a combination product comprising a competitive progesterone antagonist and a progestin for the manufacture of a medicament for treating endometriosis or leiomyomata uteri of |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195533A1 Interruption of binding of mdm2 and p53 protein and therapeutic application thereof |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194861A1 Proteins from mammalian liver and their use in oncology |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |
| 01/31/1996 | EP0694539A1 7-o-Ethers of taxane derivatives |
| 01/31/1996 | EP0694304A1 An extract of freshwater mussel, methods of the extraction and uses thereof |
| 01/31/1996 | EP0694301A1 Synergistic combination containing at least a RXR specific ligand and a RAR alpha specific ligand |
| 01/31/1996 | EP0694078A1 Method for screening for receptor agonists |
| 01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
| 01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 01/31/1996 | EP0694038A1 Novel androgens and anabolic agents |
| 01/31/1996 | EP0694035A1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 01/31/1996 | EP0456817B1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates |
| 01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 01/31/1996 | CN1115980A Dehydrogenation process |
| 01/31/1996 | CN1115979A New crystalline form of vitamin D analogue |
| 01/31/1996 | CN1115643A Anticarcinogen |
| 01/30/1996 | US5488145 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| 01/30/1996 | US5488135 Bis(phenyl)ethane derivatives |
| 01/30/1996 | US5488110 Highly water soluble bis-naphthalimides useful as anticancer agents |
| 01/30/1996 | US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/30/1996 | US5488057 2-oxindole compounds which have useful tyrosine kinase activity |
| 01/30/1996 | US5487984 Processes for producing tumor necrosis factor |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/30/1996 | CA1338011C Oncostatin m and novel compositions having anti-neoplastic activity |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001842A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | WO1996001835A1 Mammalian telomerase |
| 01/25/1996 | WO1996001827A1 Tetracyclic derivatives and their use as antitumour agents |
| 01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001655A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001640A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001633A1 New formulation for the topical treatment of psoriasis |
| 01/25/1996 | WO1996001614A2 Rna component of telomerase |
| 01/25/1996 | WO1996001611A1 Implanted device containing tumor cells for the treatment of cancer |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
| 01/25/1996 | CA2194586A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 01/25/1996 | CA2194566A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | CA2194560A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693120A1 Tumoricide t lymphocytes |
| 01/24/1996 | EP0693079A1 Derivatives of triterpenoid acids and uses thereof |
| 01/24/1996 | EP0693073A1 Bicyclic ansamycins and their use as antitumor agents |
| 01/24/1996 | EP0692973A1 Peptide coated dendritic cells as immunogens |
| 01/24/1996 | CN1115320A Nucleosides and oligonucleotides having 2'-ether groups |
| 01/23/1996 | US5486636 Chemical intermediates |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486510 Method and compositions for modulating or control of immune responses in humans |
| 01/23/1996 | US5486463 TNF-muteins |
| 01/23/1996 | US5486274 Poly-substituted phthalocyanines |
| 01/18/1996 | WO1996001429A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001121A1 Cancer therapy using lymphotoxin |
| 01/18/1996 | WO1996001108A1 Stereochemical wortmannin derivatives |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193963A1 Stereochemical wortmannin derivatives |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | CA2191696A1 Cancer therapy using lymphotoxin |